
Circular RNA Holds Promise as Cancer Biomarker
The stable structure of circRNA makes it an ideal candidate for biomarkers because it can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.
The stable structure of circRNA makes it an ideal candidate for biomarkers because it can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.
In a new paper, researchers and ethicists urge policymakers to view immortal cells differently from other biospecimens as new rules go into effect.
More funding, scientific insights and clinical advances have started to drive progress in this challenging disease, and researchers see potential for immunotherapy to revolutionize its future.
New research explains why stem cells become resistant to cancer treatment and opens a clever new way to go after them.
A new multi-institutional project is studying cancer biology and care to identify why minority children have worse cancer outcomes compared to their white peers.
Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.